These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 9424669)
21. [Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results]. van Gelder T; Hesselink DA; Roodnat JI; Ijzermans JN; Weimar W Ned Tijdschr Geneeskd; 2003 May; 147(20):955-9. PubMed ID: 12784528 [TBL] [Abstract][Full Text] [Related]
22. Calcineurin inhibitor-free immunosuppression in kidney transplantation. Guerra G; Srinivas TR; Meier-Kriesche HU Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419 [TBL] [Abstract][Full Text] [Related]
23. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147 [TBL] [Abstract][Full Text] [Related]
25. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
26. Steroid immunosuppression in kidney transplantation: a passing era. Schulak JA J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726 [No Abstract] [Full Text] [Related]
27. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370 [TBL] [Abstract][Full Text] [Related]
28. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids. Cantarovich D J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885 [TBL] [Abstract][Full Text] [Related]
29. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients. Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478 [TBL] [Abstract][Full Text] [Related]
30. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppression and immune monitoring after renal transplantation. Zand MS Semin Dial; 2005; 18(6):511-9. PubMed ID: 16398715 [TBL] [Abstract][Full Text] [Related]
33. The clinical application of monoclonal antibody therapies in renal transplantation. Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134 [TBL] [Abstract][Full Text] [Related]
34. Transplant immunopharmacology: you can fool with mother nature! Vasquez EM; Westin ED Nurs Case Manag; 1999; 4(1):37-48. PubMed ID: 10232222 [TBL] [Abstract][Full Text] [Related]
35. [Immunosuppression in organ transplantation. New substances and therapeutic approaches]. Wonigeit K Internist (Berl); 1996 Mar; 37(3):229-39. PubMed ID: 8919940 [No Abstract] [Full Text] [Related]